Recombinant multi-species MLLT3/AF9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MLLT3/AF9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables chromatin binding activity; lysine-acetylated histone binding activity; and molecular adaptor activity. Involved in several processes, including hematopoietic stem cell differentiation; positive regulation of DNA-templated transcription; and regulation of stem cell division. Acts upstream of or within negative regulation of canonical Wnt signaling pathway and positive regulation of Wnt signaling pathway, planar cell polarity pathway. Located in cytosol and nucleoplasm. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 2210011H10Rik,2610012I03Rik,3830408D16Rik,AF9,ALL1-fused gene from chromosome 9 protein,Af-9,Af9,D4Ertd321e,MLLT3,Mllt3,Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein,Protein AF-9,YEATS domain-containing protein 3,YEATS3

Target products collectionGo to MLLT3/AF9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8842-Ag-1/ GM-Tg-hg-IP8842-Ag-2 Human MLLT3/AF9 protein Human
GM-Tg-rg-IP8842-Ag-1/ GM-Tg-rg-IP8842-Ag-2 Rat MLLT3/AF9 protein Rat
GM-Tg-mg-IP8842-Ag-1/ GM-Tg-mg-IP8842-Ag-2 Mouse MLLT3/AF9 protein Mouse
GM-Tg-cynog-IP8842-Ag-1/ GM-Tg-cynog-IP8842-Ag-2 Cynomolgus/Rhesus macaque MLLT3/AF9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8842-Ag-1/ GM-Tg-felg-IP8842-Ag-2 Feline MLLT3/AF9 protein Feline
GM-Tg-cang-IP8842-Ag-1/ GM-Tg-cang-IP8842-Ag-2 Canine MLLT3/AF9 protein Canine
GM-Tg-bovg-IP8842-Ag-1/ GM-Tg-bovg-IP8842-Ag-2 Bovine MLLT3/AF9 protein Bovine
GM-Tg-equg-IP8842-Ag-1/ GM-Tg-equg-IP8842-Ag-2 Equine MLLT3/AF9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8842-Ag-1/ GM-Tg-hg-IP8842-Ag-2; GM-Tg-rg-IP8842-Ag-1/ GM-Tg-rg-IP8842-Ag-2;
GM-Tg-mg-IP8842-Ag-1/ GM-Tg-mg-IP8842-Ag-2; GM-Tg-cynog-IP8842-Ag-1/ GM-Tg-cynog-IP8842-Ag-2;
GM-Tg-felg-IP8842-Ag-1/ GM-Tg-felg-IP8842-Ag-2; GM-Tg-cang-IP8842-Ag-1/ GM-Tg-cang-IP8842-Ag-2;
GM-Tg-bovg-IP8842-Ag-1/ GM-Tg-bovg-IP8842-Ag-2; GM-Tg-equg-IP8842-Ag-1/ GM-Tg-equg-IP8842-Ag-2
Products Name MLLT3/AF9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MLLT3/AF9
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MLLT3/AF9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.